28092840|t|Suppressive effect of Spirulina fusiformis on diclofenac - induced hepato-renal injury and gastrointestinal ulcer in Wistar albino rats: A biochemical and histological approach
28092840|a|The non-steroidal anti-inflammatory drug (NSAID), diclofenac causes hepato-renal toxicity and gastric ulcer. The aim of this study was to investigate the protective effect of Spirulina fusiformis on Diclofenac - induced toxicity in Wistar albino rats. Rats were treated as follows: normal control (group I); diclofenac (50mg/kgb.w., i.p.) treated rats (group II); diclofenac - induced (50mg/kgb.w., i.p.) rats treated with Spirulina fusiformis (400mg/kgb.w., p.o.) (group III); diclofenac - induced (50mg/kgb.w., i.p.) rats treated with silymarin (25mg/kgb.w., p.o.) (group IV); Spirulina fusiformis (400mg/kgb.w., p.o.) alone treated rats (group V). Biochemical (liver and kidney functional markers) and antioxidant parameters (enzymic and non-enzymic antioxidants) were measured in the blood and tissue homogenates of the rats. Evaluation of intestinal ulcer score and assessment of liver and kidney histology were also done. Alterations in the levels of biochemical and antioxidant assays and histopathological changes in liver and kidney proved the toxic effect of diclofenac. The ulcer score was significantly increased in the diclofenac treated rats. Spirulina fusiformis showed to reduce such changes and was able to restore normal antioxidant status in the rats. Our study proves the hepato-renal and gastroprotective activity of Spirulina fusiformis in diclofenac - treated rats.
28092840	0	11	Suppressive	T169	C0205367
28092840	12	18	effect	T080	C1280500
28092840	22	42	Spirulina fusiformis	T109,T121	C0075026
28092840	46	56	diclofenac	T109,T121	C0012091
28092840	59	66	induced	T169	C0205263
28092840	67	79	hepato-renal	T023	C0545792
28092840	80	86	injury	T037	C3263722
28092840	91	113	gastrointestinal ulcer	T047	C0237938
28092840	117	135	Wistar albino rats	T015	C0034693
28092840	139	150	biochemical	T169	C0205474
28092840	155	176	histological approach	T059	C0019637
28092840	181	217	non-steroidal anti-inflammatory drug	T121	C0003211
28092840	219	224	NSAID	T121	C0003211
28092840	227	237	diclofenac	T109,T121	C0012091
28092840	245	257	hepato-renal	T023	C0545792
28092840	258	266	toxicity	T037	C0600688
28092840	271	284	gastric ulcer	T047	C0038358
28092840	302	307	study	T062	C2603343
28092840	315	326	investigate	T169	C1292732
28092840	331	348	protective effect	UnknownType	C0678771
28092840	352	372	Spirulina fusiformis	T109,T121	C0075026
28092840	376	386	Diclofenac	T109,T121	C0012091
28092840	389	396	induced	T169	C0205263
28092840	397	405	toxicity	T037	C0600688
28092840	409	427	Wistar albino rats	T015	C0034693
28092840	429	433	Rats	T015	C0034693
28092840	439	446	treated	T169	C1522326
28092840	459	473	normal control	T080	C2705716
28092840	475	480	group	T096	C0009932
28092840	485	495	diclofenac	T109,T121	C0012091
28092840	516	523	treated	T169	C1522326
28092840	524	528	rats	T015	C0034693
28092840	530	535	group	T078	C0441833
28092840	541	551	diclofenac	T109,T121	C0012091
28092840	554	561	induced	T169	C0205263
28092840	582	586	rats	T015	C0034693
28092840	587	594	treated	T169	C1522326
28092840	600	620	Spirulina fusiformis	T109,T121	C0075026
28092840	643	648	group	T078	C0441833
28092840	655	665	diclofenac	T109,T121	C0012091
28092840	668	675	induced	T169	C0205263
28092840	696	700	rats	T015	C0034693
28092840	701	708	treated	T169	C1522326
28092840	714	723	silymarin	T109,T121	C0037135
28092840	745	750	group	T078	C0441833
28092840	756	776	Spirulina fusiformis	T109,T121	C0075026
28092840	804	811	treated	T169	C1522326
28092840	812	816	rats	T015	C0034693
28092840	818	823	group	T078	C0441833
28092840	828	839	Biochemical	T169	C0205474
28092840	841	846	liver	T023	C0023884
28092840	851	857	kidney	T023	C0022646
28092840	858	868	functional	T169	C0205245
28092840	869	876	markers	T201	C0005516
28092840	882	893	antioxidant	T121	C0003402
28092840	894	904	parameters	T077	C0549193
28092840	906	913	enzymic	T116,T126	C0014442
28092840	918	942	non-enzymic antioxidants	T121	C0003402
28092840	949	957	measured	T080	C0444706
28092840	965	970	blood	T031	C0005767
28092840	975	981	tissue	T024	C0040300
28092840	982	993	homogenates	T072	C3829671
28092840	1001	1005	rats	T015	C0034693
28092840	1007	1017	Evaluation	T058	C0220825
28092840	1021	1037	intestinal ulcer	T047	C0237938
28092840	1038	1043	score	T081	C0449820
28092840	1048	1058	assessment	T052	C1516048
28092840	1062	1067	liver	T023	C0023884
28092840	1072	1078	kidney	T023	C0022646
28092840	1079	1088	histology	T091	C0019638
28092840	1105	1116	Alterations	T078	C1515926
28092840	1124	1130	levels	T080	C0441889
28092840	1134	1145	biochemical	T169	C0205474
28092840	1150	1161	antioxidant	T121	C0003402
28092840	1162	1168	assays	T059	C0005507
28092840	1173	1190	histopathological	T169	C0243140
28092840	1191	1198	changes	T169	C0392747
28092840	1202	1207	liver	T023	C0023884
28092840	1212	1218	kidney	T023	C0022646
28092840	1230	1242	toxic effect	T037	C0600688
28092840	1246	1256	diclofenac	T109,T121	C0012091
28092840	1262	1267	ulcer	T047	C0041582
28092840	1268	1273	score	T081	C0449820
28092840	1292	1301	increased	T081	C0205217
28092840	1309	1319	diclofenac	T109,T121	C0012091
28092840	1320	1327	treated	T169	C1522326
28092840	1328	1332	rats	T015	C0034693
28092840	1334	1354	Spirulina fusiformis	T109,T121	C0075026
28092840	1365	1371	reduce	T080	C0392756
28092840	1377	1384	changes	T169	C0392747
28092840	1416	1427	antioxidant	T121	C0003402
28092840	1428	1434	status	T080	C0449438
28092840	1442	1446	rats	T015	C0034693
28092840	1452	1457	study	T062	C2603343
28092840	1469	1481	hepato-renal	T023	C0545792
28092840	1515	1535	Spirulina fusiformis	T109,T121	C0075026
28092840	1539	1549	diclofenac	T109,T121	C0012091
28092840	1552	1559	treated	T169	C1522326
28092840	1560	1564	rats	T015	C0034693